ROBERT SOLIZ: Open Payments
NPI 1619434792 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 40 payments from 6 companies in 2025. Trend: 2023 $990 · 2024 $552 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $180 |
| Novo Nordisk Inc | 13 | $152 |
| ABBVIE INC. | 3 | $62 |
| Exact Sciences Corporation | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: TRELEGY ELLIPTA, Ozempic, LINZESS, Cologuard Collection Kit, ENTRESTO, Wegovy, BREZTRI, SHINGRIX.
Industry payments across TX — which companies pay providers there.
